Reader’s Guide to the Dikegulac Sodium RED and Supporting Documents:

Docket # EPA-HQ-OPP-2006-0954

	EPA has created this document to provide an organizational structure to
the dikegulac sodium docket.  The docket index lists the dikegulac
sodium items sequentially, while this document lists them by subject
matter.  The Agency is providing the “Reader’s Guide” to allow the
reader to more easily access and navigate the various items contained in
the dikegulac sodium docket.  

Federal Register and Docket Organizational Documents:

Federal Register Notice: <Dikegulac Sodium Reregistration Eligibility
Decision; Notice of Availability>

Miscellaneous Documents

Reader’s Guide to the Dikegulac Sodium RED and Supporting Documents:

Docket # EPA-HQ-OPP-2006-0954

Permethrin Reregistration Eligibility Decision

Reregistration Eligibility Decision (RED) for Dikegulac Sodium 

Technical Support Documents

Health Effects Documents

Dikegulac Sodium. Human Health Consideration for the Reregistration
Eligibility Decision.  October 31, 2006.

Dikegulac Sodium.  Addendum to the HED Risk Assessment.  February 6,
2007. 

Ecological Fate and Effects Documents

EFED Risk Assessment for the Reregistration of Dikegulac Sodium. 
October 6, 2006.

Drinking Water Assessment for Dikegulac-Sodium Reregistration
Eligibility Decision (RED).  February 9, 2007. 

 

